Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Gains from Sales and Divestitures (2022)

Historic Gains from Sales and Divestitures for Fennec Pharmaceuticals (FENC) over the last 1 years, with Q4 2022 value amounting to $26000.0.

  • Fennec Pharmaceuticals' Gains from Sales and Divestitures changed N/A to $26000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $26000.0, marking a year-over-year change of. This contributed to the annual value of $26000.0 for FY2022, which is N/A changed from last year.
  • Fennec Pharmaceuticals' Gains from Sales and Divestitures amounted to $26000.0 in Q4 2022.
  • In the past 5 years, Fennec Pharmaceuticals' Gains from Sales and Divestitures registered a high of $26000.0 during Q4 2022, and its lowest value of $26000.0 during Q4 2022.